COVID-19: Navigating practice and 'at-risk' patient pathways (Highlight Video)

Intermediate dry age-related macular degeneration (AMD) patients may be at a greater risk of undetected conversion for an extended period of time during the pandemic. Richard Garfinkel, MD from the Retina Group of Washington discusses poor wet AMD detection rates, long-term visual acuity data, and proposes a solution for better outcomes in a shorter highlights video from his webinar on the potential impact of COVID-19 on intermediate dry AMD patients. Click here to see the full webinar.